News Search Results
Aug 27, 2025, 08:30 ET Applying a Holistic Digital Endpoint Strategy in the Development of Congestive Heart Failure Treatments, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 27, 2025, 08:00 ET Actinogen trial using intended commercial Xanamem tablet formulation confirms target exposures in fed and fasted states
Limited About Actinogen Medical Actinogen Medical (ACW) is an ASX-listed, biotechnology company in the late clinical stages of development for Xanamem® (emestedastat), its novel oral therapy for Alzheimer's disease and depression. The
More news about: Actinogen Medical Limited
Aug 27, 2025, 07:00 ET Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Mass., Aug. 27, 2025 /PRNewswire/ -- Leal Therapeutics, Inc., a biotechnology company developing novel therapeutics for patients with disorders of the central nervous system (CNS), today announced a $30
More news about: Leal Therapeutics
Aug 27, 2025, 07:00 ET Adcendo ApS to Participate in Upcoming September Investor Conferences
2025Location: Boston, MAAbout Adcendo Adcendo is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts.
More news about: Adcendo
Aug 27, 2025, 07:00 ET Adcendo ApS to Participate in Upcoming September Investor Conferences
2025Location: Boston, MAAbout Adcendo Adcendo is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts.
More news about: Adcendo
Aug 27, 2025, 06:45 ET Lilly's Verzenio® (abemaciclib) increases overall survival in HR+, HER2-, high-risk early breast cancer with two years of therapy
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 27, 2025, 06:30 ET Shineco (NASDAQ: SISI) & BICC: From "Tech On-Chain" to "Global Redeemability"--RWA Ecosystem Takes Off for Long-Term Growth
the ecosystem and will continue to update on project progress." About BICC Pte Ltd Founded in 2024, BICC is an innovative biotechnology holding company that unites a world-class team of scientists and medical experts specializing in stem cell treatments and artificial intelligence.
More news about: Shineco,Inc.
Aug 27, 2025, 06:30 ET Global CAR-T Cell Therapy Market to Hit $217.6Bn by 2035 at 39.75% CAGR | Vantage Market Research
Research is a trusted partner to Fortune 500 companies and leading biopharma firms, delivering actionable market intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions and capitalize on emerging opportunities.
More news about: Vantage Market Research
Aug 27, 2025, 06:08 ET Innovent Announces 2025 Interim Results and Business Updates
from Innovent's innovative drugsInnovent has been graded 'AAA' rating in MSCI ESG rankings, positioning us at the forefront of the biotechnology industryWe have supported over 200,000 patients through our dedicated patient assistance programs, with drug donations totaling RMB
More news about: Innovent Biologics
Aug 27, 2025, 03:09 ET BPC Instruments reports results for H1 and Q2 2025
awarded one of Sweden's leading environmental prizes for its innovative work in renewable energy and environmental biotechnology. On 4 June, BPC received a 0.7 MSEK from KU Leuven, Belgium's highest-ranked university and one of the oldest
More news about: BPC Instruments AB
Aug 27, 2025, 01:34 ET Oncoinvent ASA half-yearly report: Strong focus on financial discipline and advancing Phase 2 program in ovarian cancer
webcast will be made available on our website shortly after the presentation. About Oncoinvent Oncoinvent is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The lead product candidate, Radspherin®, uses the alpha-emitting radionuclide
More news about: Oncoinvent AS
Aug 27, 2025, 01:32 ET Oncoinvent ASA half-yearly report: Strong focus on financial discipline and advancing Phase 2 program in ovarian cancer
webcast will be made available on our website shortly after the presentation. About Oncoinvent Oncoinvent is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The lead product candidate, Radspherin®, uses the alpha-emitting radionuclide
More news about: Oncoinvent AS
Aug 26, 2025, 18:00 ET WesternU receives 150-acre land gift to expand health care education in Oregon
Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, osteopathic medicine, pharmacy, physical therapy, physician
More news about: Western University of Health Sciences
Aug 26, 2025, 17:46 ET Global Digital Biomarkers Market Anticipating Remarkable Growth at a CAGR of ~17% by 2032 | DelveInsight
healthcare, digital biomarkers are emerging as a critical component in personalized medicine and remote patient monitoring. Pharmaceutical and biotechnology companies are actively integrating digital biomarkers into clinical trials to enhance patient stratification, monitor treatment adherence,
More news about: DelveInsight Business Research, LLP
Aug 26, 2025, 14:35 ET CAR-T Cell Therapy Market to Reach USD 11,142.53 million by 2032, growing at a CAGR of 12.3%: Credence Research
refractory cases, thus fueling market growth. Advancements in CAR-T Technology Continuous progress in genetic engineering and biotechnology has significantly enhanced the safety and efficacy of CAR-T therapies. Innovations such as next-generation CAR designs, improved cell expansion
More news about: Credence Research Inc.
Aug 26, 2025, 12:35 ET Activation Capital Names Michael Steele as President and CEO
entrepreneurs, and partners to bring innovation to life, right here in the Commonwealth." About Virginia Biotechnology Research Partnership Authority The Virginia Biotechnology Research Partnership Authority ("Authority") is a political subdivision of the Commonwealth of Virginia
More news about: Activation Capital
Aug 26, 2025, 12:02 ET Cerecin Joins NIHR HealthTech Research Centre in Brain Health as an Industry Partner
future innovations, both independently and in concert with other industry leaders. About Cerecin Cerecin is a US-based clinical-stage biotechnology company focused on developing drugs that target the metabolic basis of neurological diseases. Cerecin's development programs leverage its extensive
More news about: Cerecin, Inc
Aug 26, 2025, 10:06 ET Hydrosome Labs Study Links Ultrafine Bubble Water to Better Gut Health and Lower Inflammation
Hydrosome Labs, a Chicago-based biotechnology company pioneering ultrafine bubble (UFB) technology, announced groundbreaking preclinical results showing that its UFB-treated water can beneficially
More news about: Hydrosome Labs
Aug 26, 2025, 10:00 ET High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient
(Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for the treatment of severe diseases, today announced the successful treatment of the
More news about: CorrectSequence Therapeutics
Aug 26, 2025, 09:00 ET Debut Raises $20M to Fast-track AI Ingredient Discovery in Skin Longevity and Grow its Formulation Business in the US and Asia
among others. Debut The leader in biotech beauty Debut is building the future of beauty with cutting-edge AI and biotechnology, creating high-performing, innovative ingredients and formulations that propel the industry forward. The company specializes in scientifically-discovered,
More news about: Debut Biotechnology
Aug 26, 2025, 09:00 ET iNtRON Bio, files Two Patent Applications for IMPA™ Platform-Based Gene Editing Technology
https://www.prnewswire.com/news-releases/intron-bio-files-two-patent-applications-for-impa-platform-based-gene-editing-technology-302538358.html SOURCE iNtRON Biotechnology, Inc.
More news about: iNtRON Biotechnology, Inc.
Aug 26, 2025, 08:38 ET 6th Annual #GetOnBoard Week: How Women Lead Honors Visionary Impact and Advocacy in 2025
portfolios in the country—serving on more than 35 public company boards and 14 private company boards, including Costco Wholesale Corporation, Sana Biotechnology, and DocuSign, where she currently serves as Board Chair. At Costco, she has helped guide a board that continues to stand firm in its values,
More news about: How Women Lead
Aug 26, 2025, 08:31 ET MetaVia to Present at Upcoming Investor and Industry Conferences
Aug. 26, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced its participation in upcoming investor and industry conferences.
More news about: MetaVia Inc.
Aug 26, 2025, 08:30 ET p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer's Disease Research, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 26, 2025, 08:30 ET Advancing ADC Design Through Site-Specific Conjugation and Stable Linkers, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks